Denis Barrier
Co-founder and CEO @ Cathay Innovation
San Francisco, United States
Denis Barrier is a Series B investor at Cathay Innovation in San Francisco focused on Artificial Intelligence and Big Data. Denis is co-founder and CEO of Cathay Innovation. He is also a Managing Partner of Cathay Capital Private Equity.Prior to Cathay, he was at Iris Capital where he managed the international activities of the Orange/Publicis fund. He has also been the Head of Corporate Venture at Orange Telecom, and a Managing Director at Innovacom. He has alsoworked as an Officer at the French Treasury Department, in charge of all the Sovereign holdings in Aerospace, Defense, and Media companies.Denis has a deep technical background and started as a Researcher in the laboratories of Orange Telecom, working mainly on semiconductor quantum dots. He holds a Ph.D. in solid state Physics, is a graduate of Ecole Normale Supérieure, and is an engineer of Ecole Nationale Supérieure des Télécommunications. He has also been a Member of the French Council for Entrepreneurship and of Corps des Mines.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 59%
Last updated:
For AI agents: llms.txt
Industries Denis Barrier invests in
Stages Denis Barrier invests in
Countries Denis Barrier invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 6 (35%)
- Big Data 3 (18%)
- Analytics 3 (18%)
- Advertising 3 (18%)
- SaaS 2 (12%)
Stage
- Series B 5 (29%)
- Series A 3 (18%)
- Series C 3 (18%)
- Venture - Series Unknown 2 (12%)
- Series D 1 (6%)
Country
- United States 8 (47%)
- China 2 (12%)
- France 1 (6%)
- United Kingdom 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps newtherapies arrive to patients faster, and at lower prices | $20M / Series A / Mar 29, 2023 | ||
| Peek is an AI-enabled platform that supports online booking, payment processing, dynamic pricing, and guest management, while automating scheduling, waivers, communication, and analytics. With a marketplace at Peek.com, it offers travelers access to tens of thousands of curated experiences—everything from immersive exhibits and city tours toclasses and adventures. Through recent acquisitions of ACME Ticketing and Connect&GO, Peek now extends its infrastructure to include membership, donations, RFID-based visitor tracking, and on-site operations. Its clients include major institutions like MoMA, the Whitney Museum, Seattle Aquarium, Bryant Park, Looping Group, and Museum of Ice Cream. | $80M / Series C / Nov 23, 2021 | ||
| LeadIQ is transforming the sales prospecting landscape, by providing the fastest way to capture leads, discover emails and contact info, and enrich data with company information and social profiles.LeadIQ integrates with a large number of data source and finds the most comprehensive data to enrich profiles so sales teams can prequalify leads andfocus on leads that really matter. Less time spent on unqualified leads means more time for closing deals and increasing the bottom line. | $30M / Series B / Oct 01, 2021 | ||
| Unsupervised is an AI-based that finds hidden insights in complex data. It built the first AI-based on unsupervised learning that automatically discovers the most important patterns in data without requiring human guidance or supervision. It was founded in 2017 and is headquartered in Boulder, Colorado. | $35M / Series B / Apr 23, 2021 | ||
| Cloudpick Technology is a high-tech enterprise specializing in the development of computer vision and artificial intelligence applications. The company is committed to leading the technological breakthrough of the core knowledge of artificial intelligence and building an overall application solution for artificial intelligence and big data analysisin multiple industries. | Series A / Jul 20, 2020 | ||
| Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps newtherapies arrive to patients faster, and at lower prices | $14M / Series A / Feb 04, 2020 | ||
| Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.They use AI to identify new drug candidates, de-risk and accelerate clinical trials and builddiagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016.Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi. | $13M / Series A / Mar 07, 2019 | ||
| Peek is an AI-enabled platform that supports online booking, payment processing, dynamic pricing, and guest management, while automating scheduling, waivers, communication, and analytics. With a marketplace at Peek.com, it offers travelers access to tens of thousands of curated experiences—everything from immersive exhibits and city tours toclasses and adventures. Through recent acquisitions of ACME Ticketing and Connect&GO, Peek now extends its infrastructure to include membership, donations, RFID-based visitor tracking, and on-site operations. Its clients include major institutions like MoMA, the Whitney Museum, Seattle Aquarium, Bryant Park, Looping Group, and Museum of Ice Cream. | $23M / Series B / Jun 19, 2018 | ||
| Chime is a fintech company that helps its members avoid bank fees, save money automatically, and lead healthier financial lives.It offers a modern, mobile, and connected approach to banking that gives members complete control of their finances. Chime members receive a Chime debit card, a Spending Account, a Savings Account, and a powerful mobileapp that keeps members in control. The Chime mobile app is available for iPhone and Android devices and has been featured as one of the best Money Management apps in the App Store.The company was co-founded in 2013 by Chris Britt and Ryan King. | $70M / Series C / May 31, 2018 | ||
| Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.They use AI to identify new drug candidates, de-risk and accelerate clinical trials and builddiagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016.Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi. | $11M / Series A / Jan 16, 2018 | ||
| See all 17 investments → | |||
Co-Investors
About Cathay Innovation
Cathay Innovation is a multistage venture capital firm affiliated with Cathay Capital, investing in founders building transformative businesses across Europe, North America, Asia, Latin America, and Africa. Its platform connects founders with investors and its ecosystem of leading Fortune 500 corporations to help startups scale and transformindustries with consumer-to-enterprise and AI solutions in commerce, fintech, digital health, and mobility/energy. Cathay Innovation now manages over €2.5B AUM with offices in Paris, Berlin, Madrid, San Francisco, Mexico City, Shanghai, and Singapore and has invested in over 150 startups, including Chime, Pinduoduo (NASDAQ: PDD), Glovo, Wallbox (NYSE: WBX), Owkin, Ledger, ZenBusiness, Alma, Descartes Underwriting, and more.
Cathay Innovation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Rajive Keshup
Partner
|
|||
Costanza Carissimo
Director
|
|||
|
Denis Barrier
Co-founder and CEO
|
|||
Jacky Abitbol
Managing Partner
|
|||
John Li
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Denis Barrier invest in?
Denis Barrier invests primarily in Artificial Intelligence, Big Data and Analytics startups, most often at Series B and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Denis Barrier?
Public channels for Denis Barrier include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Denis Barrier last invest?
The most recent investment recorded for Denis Barrier closed in Mar 2023. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
